Leverage Shares 3x Long Moderna ETPLeverage Shares 3x Long Moderna ETPLeverage Shares 3x Long Moderna ETP

Leverage Shares 3x Long Moderna ETP

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪986.03 K‬EUR
Fund flows (1Y)
‪299.12 M‬EUR
Dividend yield (indicated)
Discount/Premium to NAV
−4.5%
Shares outstanding
‪62.31 K‬
Expense ratio
3.78%

About Leverage Shares 3x Long Moderna ETP


Issuer
Leverage Shares LLC
Brand
Leverage Shares
Inception date
Dec 14, 2021
Structure
Special Purpose Vehicle
Index tracked
iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Leverage Shares Management Co. Ltd.
ISIN
XS3005160091
The Leverage Shares 3x Long Moderna (MRNA) ETP Securities seeks to track the iSTOXX Leveraged 3x MRNA Index, which is designed to provide 3x the daily return of Moderna Inc. stock, adjusted to reflect the fees and costs of maintaining a leveraged position in the stock

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Vanilla
Geography
U.S.
Weighting scheme
Single asset
Selection criteria
Single asset

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of July 15, 2025
Exposure type
Stocks
Health Technology
Stocks300.26%
Health Technology100.00%
Bonds, Cash & Other−200.26%
Cash−200.26%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


3MRN assets under management is ‪986.03 K‬ EUR. It's risen 68.43% over the last month.
3MRN fund flows account for ‪299.12 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 3MRN doesn't pay dividends to its holders.
3MRN shares are issued by Leverage Shares LLC under the brand Leverage Shares. The ETF was launched on Dec 14, 2021, and its management style is Passive.
3MRN expense ratio is 3.78% meaning you'd have to pay 3.78% of your investment to help manage the fund.
3MRN follows the iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
3MRN invests in stocks.
3MRN price has risen by 66.88% over the last month, and its yearly performance shows a −99.80% decrease. See more dynamics on 3MRN price chart.
NAV returns, another gauge of an ETF dynamics, showed a 47.95% increase in three-month performance and has decreased by −99.81% in a year.
3MRN trades at a premium (4.47%) meaning the ETF is trading at a higher price than the calculated NAV.